Changes in Sub. S-hldr's Int (Section 138 of CA 2016)
DUOPHARMA BIOTECH BERHAD |
Particulars of substantial Securities Holder
Name | EMPLOYEES PROVIDENT FUND BOARD |
Address |
TINGKAT 19, BANGUNAN KWSP, JALAN RAJA LAUT
KUALA LUMPUR 50350 Wilayah Persekutuan Malaysia. |
Company No. | EPF ACT 1991 |
Nationality/Country of incorporation | Malaysia |
Descriptions (Class) | Ordinary Shares |
Details of changes
No | Date of change | No of securities |
Type of Transaction | Nature of Interest |
17 May 2022 | 1,073,870 |
Others | Direct Interest | |
Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
Description of "Others" Type of Transaction | DRP | |||
17 May 2022 | 11,162 |
Others | Direct Interest | |
Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
Description of "Others" Type of Transaction | DRP | |||
17 May 2022 | 930 |
Others | Direct Interest | |
Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
Description of "Others" Type of Transaction | DRP | |||
17 May 2022 | 109,900 |
Acquired | Direct Interest | |
Name of registered holder | Citigroup Nominees (Tempatan) Sdn. Bhd. | |||
Address of registered holder | Level 42, Menara Citibank, 165 Jalan Ampang, 50450 Kuala Lumpur. | |||
Description of "Others" Type of Transaction |
Circumstances by reason of which change has occurred | Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (Elected to reinvest in 1,073,870 new shares pursuant to the Dividend Reinvestment Plan ("DRP")). Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (ARIM) (Elected to reinvest in 11,162 new shares pursuant to the Dividend Reinvestment Plan ("DRP")). Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (AsianIslamic) IC (Elected to reinvest in 930 new shares pursuant to the Dividend Reinvestment Plan ("DRP")). Acquisition of 109,900 shares by Citigroup Nominees (Tempatan) Sdn. Bhd. - Employees Provident Fund Board (F.TemIslamic) IC |
Nature of interest | Indirect Interest |
Direct (units) | |
Direct (%) | |
Indirect/deemed interest (units) | 87,662,786 |
Indirect/deemed interest (%) | 9.206 |
Total no of securities after change | 87,662,786 |
Date of notice | 18 May 2022 |
Date notice received by Listed Issuer | 20 May 2022 |
Remarks : |
Total number of Duopharma Biotech Berhad shares held are as follows:- (a) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD: 78,059,595 (b) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (AM INV): 3,200,000 (c) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (ARIM): 811,162 (d)CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (TEMPLETON): 712,600 (e) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (ASIANISLAMIC) IC: 67,596 (f) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (F.TEMISLAMIC) IC: 1,246,100 (g) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (CPIAM EQ) IC: 1,849,600 (h) CITIGROUP NOMINEES (TEMPATAN) SDN. BHD. EMPLOYEES PROVIDENT FUND BOARD (NIAM EQ) IC: 1,716,133 |
Announcement Info
Company Name | DUOPHARMA BIOTECH BERHAD |
Stock Name | DPHARMA |
Date Announced | 20 May 2022 |
Category | Change in the Interest of Substantial Shareholder Pursuant to Section 138 of CA 2016 |
Reference Number | CS2-20052022-00046 |